FDA approves Takeda's first-in-class narcolepsy drug

The FDA has approved Takeda's first-in-class drug for narcolepsy, marking a significant regulatory milestone for treatment options in this sleep disorder.

This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it.